Emerging minimal-change nephrotic syndrome in a patient with chronic mesangial proliferative lupus nephritis

Internal Medicine

Volumn 46, Issue 13, 2007, Pages 991-995

  Deji, Naoko ^a   Sugimoto, Toshiro ^a   Kanasaki, Masami ^a   Aoyama, Masahiro ^a   Tanaka, Yuki ^a   Sakaguchi, Masayoshi ^a   Nishio, Yoshihiko ^a   Uzu, Takashi ^a   Kashiwagi, Atsunori ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Mesangial proliferative lupus nephritis; Minimal change nephropathy; Nephrotic syndrome; Systemic lupus erythematosus

Indexed keywords

ALBUMIN; ANTINUCLEAR ANTIBODY; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CREATININE; DIURETIC AGENT; DOUBLE STRANDED DNA ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PREDNISOLONE;

ACUTE KIDNEY FAILURE; ADULT; ANTIBODY BLOOD LEVEL; ARTHRITIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CREATININE BLOOD LEVEL; ELECTRON MICROSCOPY; FEMALE; GENERALIZED EDEMA; HUMAN; IMMUNE COMPLEX DEPOSITION; IMMUNOFLUORESCENCE TEST; KIDNEY BIOPSY; MINIMAL CHANGE NEPHROTIC SYNDROME; NEPHROTIC SYNDROME; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEIN URINE LEVEL; PROTEINURIA; SYSTEMIC LUPUS ERYTHEMATOSUS; URINALYSIS;

ACUTE DISEASE; ADULT; BIOPSY, NEEDLE; COMBINED MODALITY THERAPY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HUMANS; IMMUNOHISTOCHEMISTRY; JAPAN; KIDNEY FUNCTION TESTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; NEPHROSIS, LIPOID; SEVERITY OF ILLNESS INDEX;

EID: 34547950795     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.46.0028     Document Type: Article

References (21)

1. Churg J, Berstein J, Glassock RJ. Lupus nephritis. In: Renal Diseases, Classification and Atlas of Glomerular Diseases. 2nd ed. Igaku-Shoin, New York, 1995: 151-179.
2. D'Agati VD. Renal disease in systemic lupus erythematosus, mixed connective tissue disease, Sjögren syndrome, and rheumatoid arthritis. In: Heptinstall's Pathology of the Kidney. 6th ed. Jennette JC, Olson JL, Schwartz MM, Silva FG, Eds. Lippincott-William & Wilkins, Philadelphia, 2007: 518-612.
3. Weening JJ, D'Agati VD, Schwartz MM, et al. International Society of Nephrology Working Group on the Classification of Lupus Nephritis; Renal Pathology Society Working Group on the Classification of Lupus Nephritis. The classification of glomerulonephritis in systemic lupus erythematosus revised. Kidney Int 65: 521-530, 2004 (Erratum in Kidney Int 65:1132, 2004).
4. Baldwin DS, Gluck MC, Lowenstein J, Gallo GR. Lupus nephritis: Clinical course as related to morphological forms and their transition. Am J Med 62: 12-30, 1977.
5. Olson JL. The nephrotic syndrome and minimal change disease. In: Heptinstall's Pathology of the Kidney. 6th ed. Jennette JC, Olson JL, Schwartz MM, Silva FG, Eds. Lippincott-William & Wilkins, Philadelphia, 2007: 126-154.
6. Rose BD. Acute renal failure minimal change disease and other forms of nephritic syndrome. In: UptoDate, CD-ROM: version 14.3. Rose BD, Ed. Wellesley, MA: UptoDate; 2006.
7. Makino H, Haramoto T, Shikata K, Ogura T, Ota Z. Minimal-change nephrotic syndrome associated with systemic lupus erythematosus. Am J Nephrol 15: 431-439, 1995.
8. Nishihara G, Nakamoto M, Yasunaga C, et al. Systemic lupus erythematosus in a patient with remitting minimal change nephrotic syndrome. Clin Nephrol 48: 327-330, 1997.
9. Stankeviciute N, Jao W, Balir A, Lash JP. Mesangial lupus nephritis associated with nephrotic syndrome. J Am Soc Nephrol 8: 1199-1204, 1997.
10. Guery B, Martinez F, Beaufils H, Deray G. Minimal-change nephropathy associated with lupus erythematosus. Nephrol Dial Transplant 12: 2030, 1997.
11. Perakis C, Arvanitis A, Sotsiou F, Emmanouel DS. Nephrotic syndrome caused by minimal-change disease in a patient with focal proliferative SLE nephritis (WHO III) in remission. Nephrol Dial Transplant 13: 467-470, 1998.
12. Dube GK, Markowitz GS, Radhakrishnan J, Appel GB, D'Agati VD. Minimal change disease in systemic lupus erythematosus. Clin Nephrol 57: 120-126, 2002.
13. Seo DB, Lee SW, Song JH, Lee KJ, Han JY, Kim MJ. Acute renal failure associated with a minimal change nephrotic syndrome in a systemic lupus erythematosus patient. Yonsei Med J 43: 114-118, 2002.
14. Wang Y-T, Chou H-H, Chen F-F, Chen M-J, Chiou Y-Y. A case of minimal-change nephrotic syndrome in pediatric lupus erythematosus: just a coincidence? Lupus 15: 244-247, 2006.
15. Hertig A, Droz D, Lesavre P, Grunfeld IP, Rieu PR. SLE and idiopathic nephrotic syndrome: coincidence or not? Am J Kid Dis 40: 1179-1184, 2002.
16. Kraft SW, Schwartz MM, Korbet SM, Lewis EJ. Glomerular podocytopathy in patients with systemic lupus erythematosus. J Am Soc Nephrol 16: 175-179, 2005.
17. Han TS, Schwarz MM, Lewis EJ. Association of glomerular podocytopathy and nephrotic proteinuria in mesangial lupus nephritis. Lupus 15: 71-75, 2006.
18. Wallace DJ. The musculoskeletal system. In: Dubois's Lupus Erythematosus. 6th ed. Wallace DJ, Hahn BH, Eds. Lippincott-William & Wilkins, Philadelphia, 2002: 629-644.
19. Lauro S, Lalle M, D'Andrea MR, Vecchione A, Frati L. Nephrotic syndrome and adjuvant treatment with tamoxifen for early breast cancer. Case report and review of the literature. Anticancer Res 14: 2171-2172, 1994.
20. Sthoeger Z, Dayan M, Zinger H, et al. Treatment with tamoxifen and an anti-estradiol antibody have beneficial effects on experimental SLE via cytokine modulation. Ann NY Acad Sci 815: 367-368, 1997.
21. Wu W-M, Lin B-F, Su Y-C, Suen J-L, Chiang B-L. Tamoxifen decreases renal inflammation and alleviates disease severity in auto-immune NZB/W F1 mice. Scand J Immunol 52: 393-400, 2000.